The Latest
Ready-to-Use, Room Temp Stable, Premixed Vancomycin Injection Gets FDA Approval
Chronic Low Back Pain Study Results Indicate Benefit With Tanezumab
Keytruda Approved for the Adjuvant Treatment of Patients With Stage III Melanoma
Upadacitinib Gets FDA’s Priority Review for Treatment of Moderate to Severe RA
Intranasal Epinephrine Spray Granted Fast Track Designation
Discharge Opioid Rx for Heart Disease Patients May Impact Follow-Up
Artificially Sweetened Drinks Linked to Stroke After Menopause
Brief Anesthesia in Infancy Does Not Mar Neurodevelopment
